Summit Therapeutics: Pay

Summit Therapeutics paid CEO Robert W. Duggan $172.4K in FY2025 (Dec). No other named executive of that year is on file.

Pay$100 in the stock at the end of FY20 → $2.5K
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Manmeet S. SoniChief Operating Officer, Chief Financial Officer and Director
FY2024 (Dec)
FY2023 (Dec)
2 years
Mahkam ZanganehCo-Chief Executive Officer, President and Director
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
Robert W. DugganCo-Chief Executive Officer and Chairman
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.